4
Changes in Ownership
ArriVent BioPharma, Inc. Filed Acc 0001104659-25-014172
Options or other derivatives
- President of R&D acquired 120,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Lutzker Stuart President of R&D | 2025-02-03 | Grant or award · Stock Option (right to buy) | +120,000 | 120,000 | D | ||
Loading xslF345X05/tm256714-4_4seq1.xml…